株式会社TearExo
Kobe, JP · 1 known investors
TearExo develops a non-invasive breast cancer screening solution using tear fluid analysis to detect cancer-related biomarkers, targeting Japanese corporations seeking to improve women's health outcomes and reduce work-related absences from delayed diagnosis.